Archive

A phase 2a randomised, double-blind, placebo-controlled, parallel-group, add-on clinical trial of ebselen (SPI-1005) as a novel treatment for mania or hypomania.

Contributors: Cowen, Philip J; Godlewska, Beata R; Holder, Adele A; Macdonald, Orla; Sharpley, Ann L; Williams, Clare

Subjects: Bipolar Disorder, Hypomania, Mania

Data-Driven Identification of Unusual Prescribing Behavior: Analysis and Use of an Interactive Data Tool Using 6 Months of Primary Care Data From 6500 Practices in England

Contributors: Macdonald, Orla

Subjects: Outcome Measures, Pharmacists, Primary Care

Impact of the COVID-19 Pandemic on the Global Delivery of Mental Health Services and Telemental Health: Systematic Review

Contributors: Bale, Robert; Cipriani, Andrea; Hawton, Keith; Macdonald, Orla; Reid, Katherine

Subjects: COVID-19, Mental Health Services

COVID-19 and substance use disorders: a review of international guidelines for frontline healthcare workers of addiction services

Contributors: Cipriani, Andrea; Macdonald, Orla; Ostinelli, Edoardo; Smith, Katharine A; Zangani, Caroline

Subjects: COVID-19, Substance Use Disorders

Implementing a digital clinical decision support tool for side effects of antipsychotics: a focus group study

Contributors: Cipriani, Andrea; Henshall, Catherine; Macdonald, Orla

Subjects: Antipsychotics, Clinical Decision Making

How pharmacist prescribers can help meet the mental health consequences of COVID-19

Contributors: Broughton, Nick; Cipriani, Andrea; Geddes, John R; Macdonald, Orla; Marven, Michael; Smith, Katharine A

Subjects: COVID-19, Mental Health Services, Pharmacists, Prescribing